Vermillion Approved for a $7.5M Grant by the Cancer Prevention and Research Institute of Texas
May 21, 2015 at 09:01 AM EDT
Vermillion, Inc. (NASDAQ: VRML), a bio-analytical solutions company focused on gynecologic disease, announced today that it has been ...
